WESTMINSTER, Colo., June 21, 2022 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) today announced that Jacob Ma-Weaver has joined its Board of Directors. “We are pleased to welcome Jacob ...
ARCA biopharma is dedicated to developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The U.S. FDA has granted the ...
BROOMFIELD, Colo.--(BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular ...
ARCA Announces Death of Board Member Burton E. Sobel, Preeminent Physician Scientist and Academic Le
BROOMFIELD, Colo.--(BUSINESS WIRE)-- ARCA biopharma, Inc. (NAS: ABIO) , today announced that Burton E. Sobel, 75, a member of its Board of Directors, has died. "Burt was recognized as one of the great ...
Raymond L. Woosley, M.D., Ph.D. Appointed to ARCA biopharma Board of Directors BROOMFIELD, Colo.--(BUSINESS WIRE)-- ARCA biopharma, Inc. (NAS: ABIO) , a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback